FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2277604097> ?p ?o ?g. }

• W2277604097 endingPage "672" @default.
• W2277604097 startingPage "672" @default.
• W2277604097 abstract "Interstitial lung abnormalities have been associated with lower 6-minute walk distance, diffusion capacity for carbon monoxide, and total lung capacity. However, to our knowledge, an association with mortality has not been previously investigated.To investigate whether interstitial lung abnormalities are associated with increased mortality.Prospective cohort studies of 2633 participants from the FHS (Framingham Heart Study; computed tomographic [CT] scans obtained September 2008-March 2011), 5320 from the AGES-Reykjavik Study (Age Gene/Environment Susceptibility; recruited January 2002-February 2006), 2068 from the COPDGene Study (Chronic Obstructive Pulmonary Disease; recruited November 2007-April 2010), and 1670 from ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints; between December 2005-December 2006).Interstitial lung abnormality status as determined by chest CT evaluation.All-cause mortality over an approximate 3- to 9-year median follow-up time. Cause-of-death information was also examined in the AGES-Reykjavik cohort.Interstitial lung abnormalities were present in 177 (7%) of the 2633 participants from FHS, 378 (7%) of 5320 from AGES-Reykjavik, 156 (8%) of 2068 from COPDGene, and in 157 (9%) of 1670 from ECLIPSE. Over median follow-up times of approximately 3 to 9 years, there were more deaths (and a greater absolute rate of mortality) among participants with interstitial lung abnormalities when compared with those who did not have interstitial lung abnormalities in the following cohorts: 7% vs 1% in FHS (6% difference [95% CI, 2% to 10%]), 56% vs 33% in AGES-Reykjavik (23% difference [95% CI, 18% to 28%]), and 11% vs 5% in ECLIPSE (6% difference [95% CI, 1% to 11%]). After adjustment for covariates, interstitial lung abnormalities were associated with a higher risk of death in the FHS (hazard ratio [HR], 2.7 [95% CI, 1.1 to 6.5]; P = .03), AGES-Reykjavik (HR, 1.3 [95% CI, 1.2 to 1.4]; P < .001), COPDGene (HR, 1.8 [95% CI, 1.1 to 2.8]; P = .01), and ECLIPSE (HR, 1.4 [95% CI, 1.1 to 2.0]; P = .02) cohorts. In the AGES-Reykjavik cohort, the higher rate of mortality could be explained by a higher rate of death due to respiratory disease, specifically pulmonary fibrosis.In 4 separate research cohorts, interstitial lung abnormalities were associated with a greater risk of all-cause mortality. The clinical implications of this association require further investigation." @default.
• W2277604097 created "2016-06-24" @default.
• W2277604097 creator A5000242219 @default.
• W2277604097 creator A5000312215 @default.
• W2277604097 creator A5000325789 @default.
• W2277604097 creator A5000898795 @default.
• W2277604097 creator A5001253697 @default.
• W2277604097 creator A5002081827 @default.
• W2277604097 creator A5002685368 @default.
• W2277604097 creator A5008555938 @default.
• W2277604097 creator A5011066912 @default.
• W2277604097 creator A5011527598 @default.
• W2277604097 creator A5018495347 @default.
• W2277604097 creator A5018722034 @default.
• W2277604097 creator A5019130885 @default.
• W2277604097 creator A5019300254 @default.
• W2277604097 creator A5026585250 @default.
• W2277604097 creator A5034439885 @default.
• W2277604097 creator A5035400733 @default.
• W2277604097 creator A5035524361 @default.
• W2277604097 creator A5035956695 @default.
• W2277604097 creator A5042710068 @default.
• W2277604097 creator A5047234832 @default.
• W2277604097 creator A5047722887 @default.
• W2277604097 creator A5050425677 @default.
• W2277604097 creator A5053091216 @default.
• W2277604097 creator A5053755396 @default.
• W2277604097 creator A5057919043 @default.
• W2277604097 creator A5059122240 @default.
• W2277604097 creator A5062538082 @default.
• W2277604097 creator A5064775862 @default.
• W2277604097 creator A5065789326 @default.
• W2277604097 creator A5069854182 @default.
• W2277604097 creator A5070425018 @default.
• W2277604097 creator A5072182855 @default.
• W2277604097 creator A5072295805 @default.
• W2277604097 creator A5072863758 @default.
• W2277604097 creator A5075690045 @default.
• W2277604097 creator A5079665496 @default.
• W2277604097 creator A5084614356 @default.
• W2277604097 creator A5091376137 @default.
• W2277604097 date "2016-02-16" @default.
• W2277604097 modified "2023-10-18" @default.
• W2277604097 title "Association Between Interstitial Lung Abnormalities and All-Cause Mortality" @default.
• W2277604097 cites W1548223836 @default.
• W2277604097 cites W1605635602 @default.
• W2277604097 cites W1985846684 @default.
• W2277604097 cites W1991196467 @default.
• W2277604097 cites W2002726093 @default.
• W2277604097 cites W2006750439 @default.
• W2277604097 cites W2032894305 @default.
• W2277604097 cites W2052397837 @default.
• W2277604097 cites W2063561303 @default.
• W2277604097 cites W2066135143 @default.
• W2277604097 cites W2079077297 @default.
• W2277604097 cites W2079715049 @default.
• W2277604097 cites W2081772751 @default.
• W2277604097 cites W2082907106 @default.
• W2277604097 cites W2083384274 @default.
• W2277604097 cites W2091025758 @default.
• W2277604097 cites W2098530232 @default.
• W2277604097 cites W2108563169 @default.
• W2277604097 cites W2114970103 @default.
• W2277604097 cites W2116000536 @default.
• W2277604097 cites W2122590281 @default.
• W2277604097 cites W2134215992 @default.
• W2277604097 cites W2134242123 @default.
• W2277604097 cites W2136039969 @default.
• W2277604097 cites W2138871107 @default.
• W2277604097 cites W2139347600 @default.
• W2277604097 cites W2141339218 @default.
• W2277604097 cites W2142560075 @default.
• W2277604097 cites W2145796282 @default.
• W2277604097 cites W2153785016 @default.
• W2277604097 cites W2167383172 @default.
• W2277604097 cites W2168666423 @default.
• W2277604097 cites W2416914730 @default.
• W2277604097 doi "https://doi.org/10.1001/jama.2016.0518" @default.
• W2277604097 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4828973" @default.
• W2277604097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26881370" @default.
• W2277604097 hasPublicationYear "2016" @default.
• W2277604097 type Work @default.
• W2277604097 sameAs 2277604097 @default.
• W2277604097 citedByCount "302" @default.
• W2277604097 countsByYear W22776040972016 @default.
• W2277604097 countsByYear W22776040972017 @default.
• W2277604097 countsByYear W22776040972018 @default.
• W2277604097 countsByYear W22776040972019 @default.
• W2277604097 countsByYear W22776040972020 @default.
• W2277604097 countsByYear W22776040972021 @default.
• W2277604097 countsByYear W22776040972022 @default.
• W2277604097 countsByYear W22776040972023 @default.
• W2277604097 crossrefType "journal-article" @default.
• W2277604097 hasAuthorship W2277604097A5000242219 @default.
• W2277604097 hasAuthorship W2277604097A5000312215 @default.
• W2277604097 hasAuthorship W2277604097A5000325789 @default.
• W2277604097 hasAuthorship W2277604097A5000898795 @default.
• W2277604097 hasAuthorship W2277604097A5001253697 @default.

• next